News
Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...
European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...
The $1.7 trillion revenue prescription drug industry has a relatively robust immunity to tariffs. Last Wednesday, when U.S.
5d
Pharmaceutical Technology on MSNPharma industry dodges tariff blow but still braces for disruptionAccording to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...
4d
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Pharma stocks plummet as Trump signals steep tariffs on India's drug exports, with concerns over higher costs and profit ...
However, it appears that the pharma industry has avoided a big blow – for now. A factsheet released by the White House said that finished pharmaceuticals are not subject to the reciprocal tariff.
The pharmaceutical industry, the largest sector for international trade behind electronics, has so far escaped tariffs from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results